About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Florida | 702 Studies

Clinical Trials LymphomaFlorida

Lymphoma Clinical Trials in Florida

Find 702 clinical trials for lymphoma near Florida. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 702 trials

Active not recruitingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaThe purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritamab, an antibody also known as EPKINLY™…NCT03625037·Phoenix, Arizona and 84 others

PreviousPage 2 of 36Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingMB-105 in Patients With CD5 Positive T-cell LymphomaThis is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).NCT06534060·San Diego, California and 11 others

CompletedA Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaThis is a nonrandomized study of ruxolitinib in combination with a standard multi-agent chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia.NCT02723994·Birmingham, Alabama and 110 others

CompletedA Phase II Study Evaluating the Safety and Efficacy of Subcutaneous PlerixaforThis is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in recipients with hematological malignancies.NCT01696461·Tampa, Florida and 11 others

CompletedDuvelisib in Combination With BMS-986345 in Lymphoid MalignancyThe purpose of the study is to find a safe dose and to evaluate the safety and tolerability of the drug BMS-986345, in combination with duvelisib.NCT05065866·Tampa, Florida

CompletedA Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)This study will evaluate the safety, efficacy, and pharmacokinetics of induction treatment with obinutuzumab, polatuzumab vedotin, and venetoclax in participants with relapsed or…NCT02611323·Tucson, Arizona and 22 others

CompletedPomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular LymphomaThis phase I trial studies the side effects and best dose of pomalidomide when given together with dexamethasone in treating patients with primary central nervous system lymphoma…NCT01722305·Scottsdale, Arizona and 6 others

CompletedSafety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell LymphomaThis study will determine the maximum dose of KW-0761 administered intravenously that can be given safely in subjects with previously treated peripheral T-cell lymphoma (PTCL) or…NCT00888927·Los Angeles, California and 4 others

RecruitingStudy of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLThe study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large…NCT05952024·Berkeley, California and 56 others

CompletedCytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)The purpose of this trial is to evaluate a CMV vaccine given to related donor/recipient pairs (donors prior to peripheral blood stem cell donation and CMV-seropositive recipients…NCT00285259·Tucson, Arizona and 21 others

TerminatedA Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell LymphomaThis 2-arm study was designed to compare the efficacy and safety of bevacizumab (Avastin) in combination with rituximab (MabThera) and CHOP (cyclophosphamide, hydroxydaunorubicin…NCT00486759·La Jolla, California and 265 others

Active not recruitingEvolut™ EXPAND TAVR II Pivotal TrialObtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.NCT05149755·Birmingham, Alabama and 93 others

CompletedStudy of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)This study is a phase 1, dose finding, open-label study in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).NCT02658968·San Diego, California and 9 others

CompletedIPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell LymphomaThis is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as…NCT03902184·Birmingham, Alabama and 52 others

CompletedBrentuximab Vedotin Plus AVD in Limited-stage Hodgkin LymphomaBrentuximab is an antibody-drug conjugate (ADC), which is the combination of an antibody (a protein that binds to cells) and a chemotherapy molecule.NCT01534078·Tampa, Florida and 3 others

CompletedPhase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersThe study of safety of a new organic arsenic compound in the treatment of hematological malignancies.NCT00421213·Miami, Florida and 5 others

TerminatedLong-Term Follow-Up Study of Subjects Treated With ACTR T Cell ProductSubjects treated with an ACTR product may participate in this long-term follow-up study after the completion of the final scheduled visit in the parent clinical study or other…NCT02840110·Gilbert, Arizona and 15 others

RecruitingLoncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular LymphomaThe purpose of this research is to see if Loncastuximab Tesirine in combination with Rituximab will result in higher complete response rate when given to treat follicular lymphoma.NCT04998669·Fort Myers, Florida and 4 others

UnknownSafety and Efficacy of OT-82 in Participants With Relapsed or Refractory LymphomaThis research study will test OT-82, which is an investigational ("research" or "experimental" ) drug. The study has two stages (Stage 1 and Stage 2).NCT03921879·Birmingham, Alabama and 7 others

Active not recruitingBrentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLParticipants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment.NCT04404283·Birmingham, Alabama and 142 others

Other Conditions in Florida

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia